BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3080694)

  • 1. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
    Mitsumoto H; Salgado ED; Negroski D; Hanson MR; Salanga VD; Wilber JF; Wilbourn AJ; Breuer AC; Leatherman J
    Neurology; 1986 Feb; 36(2):152-9. PubMed ID: 3080695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
    Caroscio JT; Cohen JA; Zawodniak J; Takai V; Shapiro A; Blaustein S; Mulvihill MN; Loucas SP; Gudesblatt M; Rube D
    Neurology; 1986 Feb; 36(2):141-5. PubMed ID: 3080693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis: a double-blind crossover trial of thyrotropin-releasing hormone.
    Imoto K; Saida K; Iwamura K; Saida T; Nishitani H
    J Neurol Neurosurg Psychiatry; 1984 Dec; 47(12):1332-4. PubMed ID: 6439824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of amyotrophic lateral sclerosis with the TRH analog DN-1417.
    Hawley RJ; Kratz R; Goodman RR; McCutchen CB; Sirdofsky M; Hanson PA
    Neurology; 1987 Apr; 37(4):715-7. PubMed ID: 3104820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrathecal thyrotropin-releasing hormone therapy of amyotrophic lateral sclerosis.
    Stober T; Schimrigk K; Dietzsch S; Thielen T
    J Neurol; 1985; 232(1):13-4. PubMed ID: 3923160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of amyotrophic lateral sclerosis with thyrotropin-releasing hormone (TRH).
    Yamane K; Osawa M; Kobayashi I; Maruyama S
    Jpn J Psychiatry Neurol; 1986 Jun; 40(2):179-87. PubMed ID: 3097367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
    Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
    Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous thyrotropin-releasing hormone in patients with amyotrophic lateral sclerosis. Dose-response and randomized concurrent placebo-controlled pilot studies.
    Brooks BR; Sufit RL; Montgomery GK; Beaulieu DA; Erickson LM
    Neurol Clin; 1987 Feb; 5(1):143-58. PubMed ID: 3104750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1987 Oct; 22(4):541-3. PubMed ID: 3124710
    [No Abstract]   [Full Text] [Related]  

  • 12. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D
    Neurol Clin; 1987 Feb; 5(1):159-70. PubMed ID: 3104751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.
    Engel WK; Siddique T; Nicoloff JT
    Lancet; 1983 Jul; 2(8341):73-5. PubMed ID: 6134961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary clinical study on the treatment of amyotrophic lateral sclerosis with TRH].
    Formisano R; Antonini G; Bove R; Millefiorini M; Ruggieri S
    Clin Ter; 1986 Dec; 119(6):479-81. PubMed ID: 3102155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of amyotrophic lateral sclerosis with TRH].
    Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A
    Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trials of 1-cysteine, TRH and 5HTP in amyotrophic lateral sclerosis].
    Akiguchi I; Kato T; Sugiyama H
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1270-3. PubMed ID: 6442975
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
    Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged intrathecal infusion of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D; Jackson IM
    Ann N Y Acad Sci; 1988; 531():187-93. PubMed ID: 3132882
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
    Chiodini PG; Attanasio R; Liuzzi A; Cozzi R; Orlandi P; De Palo C; Dallabonzana D; Girotti F; Testa D
    J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.